| Variables |
Treatment group (with TXA and MBLPA) (n=44) |
Control group (without TXA or MBLPA) (n=43) |
P value | ||
|---|---|---|---|---|---|
|
Mean ± SD n(%) |
Mean ± SD n(%) |
Mean ± SD n(%) |
(Max-Min) | ||
| Postoperative laboratory tests | |||||
| Hb 24h (g/dL) | 11.8±1.1 | (9.1-13.7) | 10.7±1.1 | (8.3-13.1) | 0.000† |
| Hb 48h (g/dL) | 11.2±1.2 | (8.4-13.4) | 9.7±1.6 | (7.1-14.4) | 0.000† |
| Hb 5d (g/dL) | 11.4±2.0 | (8.5-15.2) | 10.4±1.4 | (7.8-13.4) | 0.073† |
| Haematocrit 24h (%) | 35.9±3.3 | (27.3-42.4) | 32.2±3.4 | (26.3-38.3) | 0.000† |
| Haematocrit 48h (%) | 34.1±3.7 | (26.0-41.7) | 30.0±5.1 | (20.7-45.9) | 0.000† |
| Haematocrit 5d (%) | 34.8±5.9 | (24.8-44.4) | 30.5±8.6 | (2.1-41.5) | 0.103* |
| Laboratory test differences with preoperative determinations | |||||
| Hb 24h (g/dL) | -2.4±1.2 | -(4.8-0.5) | -3.2±1.6 | -(7.3-0.0) | 0.006† |
| Hb 48h (g/dL) | -2.9±1.3 | -(5.1-0.2) | -3.9±1.7 | -(8.2- -0.7) | 0.007† |
| Hb 5d (g/dL) | -2.8±1.9 | -(5.5-1.3) | -3.4±1.8 | -(5.9-0.4) | 0.267† |
| Haematocrit 24h (%) | -7.2±3.9 | -(14.9-1.8) | -10.1±4.5 | -(21.9- -0.8) | 0.002† |
| Haematocrit 48h (%) | -9.0±3.9 | -(15.7-0.8) | -11.3±5.1 | -(27.4- -3.1) | 0.030† |
| Haematocrit 5d (%) | -8.2±5.6 | -(17.7-1.8) | -11.1±8.7 | -(38.1-2.2) | 0.256* |